Results 11 to 20 of about 3,996,806 (388)
Use of antifungal drugs in hematology [PDF]
Revista Brasileira de Hematologia e Hemoterapia, 2012 Invasive fungal disease represents a major complication in hematological patients. Antifungal agents are frequently used in hematologic patients for different purposes.
Marcio Nucci
doaj +6 more sources
Antifungal Nanomaterials: Current Progress and Future Directions [PDF]
Innovations in Digital Health, Diagnostics, and Biomarkers, 2021 Fungal infection poses a severe threat to human health worldwide resulting in a serious problem in clinic. Due to the limited arsenal of existing antifungal drugs, the nanomaterials were thus regarded as the candidate for developing new antifungal drugs.
Jia-Le Xu +4 more
doaj +1 more source
Antifungal Drug Resistance [PDF]
Clinical Infectious Diseases, 2003 The increasing incidence of invasive fungal infections is the result of many factors, including an increasing number of patients with severe immunosuppression. Although new drugs have been introduced to combat this problem, the development of resistance to antifungal drugs has become increasingly apparent, especially in patients who require long-term ...
Juergen Loeffler, David A. Stevens
openalex +4 more sources
Frontiers in Pharmacology, 2022 Triazole antifungal drugs (TAD) are widely used to treat invasive fungal infections due to their broad antifungal spectrum and low toxicity. Despite their preference in the clinic, multiple Adverse Events (AE) are still reported each year.
Jianxing Zhou +8 more
doaj +1 more source
Development and research progress of anti-drug resistant fungal drugs
Journal of Infection and Public Health, 2022 With the widespread use of immunosuppressive agents and the increase in patients with severe infections, the incidence of fungal infections worldwide has increased year by year.
Xiangyi Cui +3 more
doaj +1 more source
Antifungal and Immunomodulatory Ingredients from Traditional Chinese Medicine
Antibiotics, 2022 Fungal infections have become a growing public health challenge due to the clinical transmission of pathogenic fungi. The currently available antifungal drugs leave very limited choices for clinical physicians to deal with such situation, not to mention ...
Hua Zhong, Lei Han, Ren-Yi Lu, Yan Wang
doaj +1 more source
Antifungal Drug Repurposing [PDF]
Antibiotics, 2020 Control of fungal pathogens is increasingly problematic due to the limited number of effective drugs available for antifungal therapy. Conventional antifungal drugs could also trigger human cytotoxicity associated with the kidneys and liver, including the generation of reactive oxygen species.
Jong H. Kim +7 more
openaire +4 more sources
Antifungal Polymeric Materials and Nanocomposites
Frontiers in Bioengineering and Biotechnology, 2021 Rising global populations due to medicinal advancements increases the patient population susceptible to superficial and severe fungal infections. Fungi often implicated in these diseases includes the dermatophytes (Microsporum spp., Epidermophtyon spp ...
Winnie Ntow-Boahene +2 more
doaj +1 more source
Nanoliposome-loaded antifungal drugs for dermal administration: A review
Current Medical Mycology, 2021 Cutaneous fungal infections are the fourth most common health problem, which involves approximately one billion people worldwide. Drug delivery to the skin seems to be the best choice for superficial fungal infections.
P. Asadi +4 more
semanticscholar +1 more source
Expandable and reversible copy number amplification drives rapid adaptation to antifungal drugs
eLife, 2020 Previously, we identified long repeat sequences that are frequently associated with genome rearrangements, including copy number variation (CNV), in many diverse isolates of the human fungal pathogen Candida albicans (Todd et al., 2019).
R. Todd, Anna Selmecki
semanticscholar +1 more source